{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:07:30Z","timestamp":1775099250621,"version":"3.50.1"},"reference-count":33,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2024]]},"DOI":"10.1620\/tjem.2024.j013","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T22:12:59Z","timestamp":1707343979000},"page":"263-268","source":"Crossref","is-referenced-by-count":5,"title":["Anamorelin Induced Acute Hyperglycemia in a Patient with Advanced Pancreatic Cancer and Diabetes: A Case Report"],"prefix":"10.1620","volume":"262","author":[{"given":"Junpei","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Division of Metabolism and Diabetes, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Onodera","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Diabetes, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kaminaga","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Diabetes, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Kayaba","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Diabetes, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Usui","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Diabetes, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aggarwal, G., Kamada, P. &amp; Chari, S.T. (2013)  Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers.  <i>Pancreas<\/i>, 42, 198-201.","DOI":"10.1097\/MPA.0b013e3182592c96"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Akamizu, T. &amp; Kangawa, K. (2010)  Ghrelin for cachexia.  <i>J. Cachexia Sarcopenia Muscle<\/i>, 1, 169-176.","DOI":"10.1007\/s13539-010-0011-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Arends, J., Strasser, F., Gonella, S., Solheim, T.S., Madeddu, C., Ravasco, P., Buonaccorso, L., de van der Schueren, M.A.E., Baldwin, C., Chasen, M. &amp; Ripamonti, C.I. (2021)  Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines(\u2606).  <i>ESMO Open<\/i>, 6, 100092.","DOI":"10.1016\/j.esmoop.2021.100092"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Argil\u00e9s, J.M. &amp; Stemmler, B. (2013)  The potential of ghrelin in the treatment of cancer cachexia.  <i>Expert Opin. Biol. Ther.<\/i>, 13, 67-76.","DOI":"10.1517\/14712598.2013.727390"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Baazim, H., Antonio-Herrera, L. &amp; Bergthaler, A. (2022)  The interplay of immunology and cachexia in infection and cancer.  <i>Nat. Rev. Immunol.<\/i>, 22, 309-321.","DOI":"10.1038\/s41577-021-00624-w"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Chen, J.A., Splenser, A., Guillory, B., Luo, J., Mendiratta, M., Belinova, B., Halder, T., Zhang, G., Li, Y.P. &amp; Garcia, J.M. (2015)  Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.  <i>J. Cachexia Sarcopenia Muscle<\/i>, 6, 132-143.","DOI":"10.1002\/jcsm.12023"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Chuang, J.C., Sakata, I., Kohno, D., Perello, M., Osborne-Lawrence, S., Repa, J.J. &amp; Zigman, J.M. (2011)  Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells.  <i>Mol. Endocrinol.<\/i>, 25, 1600-1611.","DOI":"10.1210\/me.2011-1001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Currow, D., Temel, J.S., Abernethy, A., Milanowski, J., Friend, J. &amp; Fearon, K.C. (2017)  ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC)  patients with cachexia.  <i>Ann. Oncol.<\/i>, 28, 1949-1956.","DOI":"10.1093\/annonc\/mdx192"},{"key":"9","doi-asserted-by":"crossref","unstructured":"DeBoer, M.D., Zhu, X.X., Levasseur, P., Meguid, M.M., Suzuki, S., Inui, A., Taylor, J.E., Halem, H.A., Dong, J.Z., Datta, R., Culler, M.D. &amp; Marks, D.L. (2007)  Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia.  <i>Endocrinology<\/i>, 148, 3004-3012.","DOI":"10.1210\/en.2007-0016"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Dimitriadis, G., Mitrou, P., Lambadiari, V., Maratou, E. &amp; Raptis, S.A. (2011)  Insulin effects in muscle and adipose tissue.  <i>Diabetes Res. Clin. Pract.<\/i>, 93 Suppl 1, S52-59.","DOI":"10.1016\/S0168-8227(11)70014-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Fearon, K., Strasser, F., Anker, S.D., Bosaeus, I., Bruera, E., Fainsinger, R.L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., Davis, M., Muscaritoli, M., Ottery, F., Radbruch, L., Ravasco, P., et al.  (2011)  Definition and classification of cancer cachexia: an international consensus.  <i>Lancet Oncol.<\/i>, 12, 489-495.","DOI":"10.1016\/S1470-2045(10)70218-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Fearon, K.C., Glass, D.J. &amp; Guttridge, D.C. (2012)  Cancer cachexia: mediators, signaling, and metabolic pathways.  <i>Cell Metab.<\/i>, 16, 153-166.","DOI":"10.1016\/j.cmet.2012.06.011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Fouladiun, M., K\u00f6rner, U., Bosaeus, I., Daneryd, P., Hyltander, A. &amp; Lundholm, K.G. (2005)  Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.  <i>Cancer<\/i>, 103, 2189-2198.","DOI":"10.1002\/cncr.21013"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Garcia, J.M., Friend, J. &amp; Allen, S. (2013)  Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.  <i>Support. Care Cancer<\/i>, 21, 129-137.","DOI":"10.1007\/s00520-012-1500-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hamauchi, S., Furuse, J., Takano, T., Munemoto, Y., Furuya, K., Baba, H., Takeuchi, M., Choda, Y., Higashiguchi, T., Naito, T., Muro, K., Takayama, K., Oyama, S., Takiguchi, T., Komura, N. &amp; Tamura, K. (2019)  A multicenter, open-label, single-arm study of anamorelin (ONO-7643)  in advanced gastrointestinal cancer patients with cancer cachexia.  <i>Cancer<\/i>, 125, 4294-4302.","DOI":"10.1002\/cncr.32406"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hart, P.A., Bellin, M.D., Andersen, D.K., Bradley, D., Cruz-Monserrate, Z., Forsmark, C.E., Goodarzi, M.O., Habtezion, A., Korc, M., Kudva, Y.C., Pandol, S.J., Yadav, D. &amp; Chari, S.T. (2016)  Type 3c (pancreatogenic)  diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.  <i>Lancet Gastroenterol. Hepatol<\/i>, 1, 226-237.","DOI":"10.1016\/S2468-1253(16)30106-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Heppner, K.M. &amp; Tong, J. (2014)  Mechanisms in endocrinology: regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions.  <i>Eur. J. Endocrinol.<\/i>, 171, R21-32.","DOI":"10.1530\/EJE-14-0183"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Hiura, Y., Takiguchi, S., Yamamoto, K., Takahashi, T., Kurokawa, Y., Yamasaki, M., Nakajima, K., Miyata, H., Fujiwara, Y., Mori, M., Kangawa, K. &amp; Doki, Y. (2012)  Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study.  <i>Cancer<\/i>, 118, 4785-4794.","DOI":"10.1002\/cncr.27430"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Katakami, N., Uchino, J., Yokoyama, T., Naito, T., Kondo, M., Yamada, K., Kitajima, H., Yoshimori, K., Sato, K., Saito, H., Aoe, K., Tsuji, T., Takiguchi, Y., Takayama, K., Komura, N., et al.  (2018)  Anamorelin (ONO-7643)  for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).  <i>Cancer<\/i>, 124, 606-616.","DOI":"10.1002\/cncr.31128"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H. &amp; Kangawa, K. (1999)  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.  <i>Nature<\/i>, 402, 656-660.","DOI":"10.1038\/45230"},{"key":"21","doi-asserted-by":"crossref","unstructured":"M\u00fcller, T.D., Nogueiras, R., Andermann, M.L., Andrews, Z.B., Anker, S.D., Argente, J., Batterham, R.L., Benoit, S.C., Bowers, C.Y., Broglio, F., Casanueva, F.F., D\u2019Alessio, D., Depoortere, I., Geliebter, A., Ghigo, E., et al.  (2015)  Ghrelin.  <i>Mol. Metab.<\/i>, 4, 437-460.","DOI":"10.1016\/j.molmet.2015.03.005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Naito, T., Uchino, J., Kojima, T., Matano, Y., Minato, K., Tanaka, K., Mizukami, T., Atagi, S., Higashiguchi, T., Muro, K., Takayama, K., Furuse, J., Morishima, E., Takiguchi, T. &amp; Tamura, K. (2022)  A multicenter, open-label, single-arm study of anamorelin (ONO-7643)  in patients with cancer cachexia and low body mass index.  <i>Cancer<\/i>, 128, 2025-2035.","DOI":"10.1002\/cncr.34154"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Neary, N.M., Small, C.J., Wren, A.M., Lee, J.L., Druce, M.R., Palmieri, C., Frost, G.S., Ghatei, M.A., Coombes, R.C. &amp; Bloom, S.R. (2004)  Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial.  <i>J. Clin. Endocrinol. Metab.<\/i>, 89, 2832-2836.","DOI":"10.1210\/jc.2003-031768"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Nishikawa, H., Goto, M., Fukunishi, S., Asai, A., Nishiguchi, S. &amp; Higuchi, K. (2021)  Cancer cachexia: its mechanism and clinical significance.  <i>Int. J. Mol. Sci.<\/i>, 22, 8491.","DOI":"10.3390\/ijms22168491"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Ohta, H., Horii, T. &amp; Yasu, T. (2023)  Adverse metabolic effects on glucose in patients receiving anamorelin using a Japanese claims database.  <i>Oncology<\/i>, 101, 782-785.","DOI":"10.1159\/000533539"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Pietra, C., Takeda, Y., Tazawa-Ogata, N., Minami, M., Yuanfeng, X., Duus, E.M. &amp; Northrup, R. (2014)  Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile.  <i>J. Cachexia Sarcopenia Muscle<\/i>, 5, 329-337.","DOI":"10.1007\/s13539-014-0159-5"},{"key":"27","unstructured":"Shimizu, Y., Nagaya, N., Isobe, T., Imazu, M., Okumura, H., Hosoda, H., Kojima, M., Kangawa, K. &amp; Kohno, N. (2003)  Increased plasma ghrelin level in lung cancer cachexia.  <i>Clin. Cancer Res.<\/i>, 9, 774-778."},{"key":"28","doi-asserted-by":"crossref","unstructured":"Takayama, K., Katakami, N., Yokoyama, T., Atagi, S., Yoshimori, K., Kagamu, H., Saito, H., Takiguchi, Y., Aoe, K., Koyama, A., Komura, N. &amp; Eguchi, K. (2016)  Anamorelin (ONO-7643)  in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.  <i>Support. Care Cancer<\/i>, 24, 3495-3505.","DOI":"10.1007\/s00520-016-3144-z"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Takeda, T., Sasaki, T., Okamoto, T., Ishitsuka, T., Yamada, M., Nakagawa, H., Mie, T., Furukawa, T., Kasuga, A., Matsuyama, M., Ozaka, M. &amp; Sasahira, N. (2023)  Impact of the extent of weight loss before administration on the efficacy of anamorelin in advanced pancreatic cancer patients with cachexia.  <i>Intern. Med.<\/i>, 62, 1887-1893.","DOI":"10.2169\/internalmedicine.0730-22"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Temel, J.S., Abernethy, A.P., Currow, D.C., Friend, J., Duus, E.M., Yan, Y. &amp; Fearon, K.C. (2016)  Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.  <i>Lancet Oncol.<\/i>, 17, 519-531.","DOI":"10.1016\/S1470-2045(15)00558-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Vestergaard, E.T., Gormsen, L.C., Jessen, N., Lund, S., Hansen, T.K., Moller, N. &amp; Jorgensen, J.O. (2008)  Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling.  <i>Diabetes<\/i>, 57, 3205-3210.","DOI":"10.2337\/db08-0025"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Yada, T., Damdindorj, B., Rita, R.S., Kurashina, T., Ando, A., Taguchi, M., Koizumi, M., Sone, H., Nakata, M., Kakei, M. &amp; Dezaki, K. (2014)  Ghrelin signalling in <i>\u03b2<\/i>-cells regulates insulin secretion and blood glucose.  <i>Diabetes Obes. Metab.<\/i>, 16 Suppl 1, 111-117.","DOI":"10.1111\/dom.12344"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Zhang, H. &amp; Garcia, J.M. (2015)  Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.  <i>Expert Opin. Pharmacother.<\/i>, 16, 1245-1253.","DOI":"10.1517\/14656566.2015.1041500"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/262\/4\/262_2024.J013\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T03:20:58Z","timestamp":1714792858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/262\/4\/262_2024.J013\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j013","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"2024.J013"}}